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Abstract
Emerging research has highlighted the importance of leptin in fetal growth and
development, independent of its essential role in the regulation of feeding and
energy metabolism. Leptin is now considered an important signaling molecule of
the reproductive system, since it regulates the production of gonadotropins, the
blastocyst formation and implantation, the normal placentation, as well as the feto-
placental communication. Placental leptin is an important cytokine which regulates
placental functions in an autocrine or paracrine manner. Leptin seems to play a
crucial role during the first stages of pregnancy as it modulates critical processes like
proliferation, protein synthesis, invasion, and apoptosis in placental cells. Further-
more, deregulation of leptin levels has been correlated with the pathogenesis of
various disorders associated with reproduction and gestation, including gestational
diabetes mellitus (GDM). Due to the relevant incidence of the GDM and the
importance of leptin, we decided to review the latest information available about
leptin action in normal and GDM pregnancies to support the idea of leptin as an
important factor and/or predictor of diverse disorders associated with reproduction
and pregnancy.
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1. Introduction
Adipose tissue acts as an endocrine organ, secreting different molecules or
adipokines. A link between body weight, adipokines, and success of pregnancy has
been proposed, although it is not fully understood [1]. Leptin was the first adipokine
claimed to be the “missing link” between fat and reproduction [2]. Leptin is consid-
ered as a pleiotropic hormone that regulates not only body weight but also many other
functions, including the normal physiology of the reproductive system [3]. Impor-
tantly, this hormone is also produced by other tissues, especially placenta [4].
Placental formation during human gestation is crucial for embryonic progress
and successful pregnancy outcome, allowing metabolic exchange and producing
steroids, hormones, growth factors, and cytokines that are critical for the mainte-
nance of pregnancy [5, 6]. Trophoblast cells play an essential role in the develop-
ment of placenta. These cells differentiate in two distinct types: extravillous and
villous trophoblast. In the extravillous pathway, cytotrophoblasts proliferate,
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differentiate into an invasive phenotype, and penetrate in the maternal decidua and
myometrium. Meanwhile, in the villous pathway, mononuclear cytotrophoblasts
fuse to form a specialized multinuclear syncytium called syncytiotrophoblast [7]. In
normal pregnancy, trophoblast invasion is a critical step in remodeling the maternal
spiral arteries to adequately perfuse the developing placenta and fetus [8]. In this
sense, deregulation of leptin levels has been implicated in the pathogenesis of
gestational diabetes mellitus (GDM) [9].
2. Leptin and reproduction
Reproductive function depends on the energy reserves stored in the adipose
tissue. The large energy needs for a hypothetical pregnancy was the original ratio-
nale to explain the disruption of reproductive function by low fat reserves. This led
to the hypothesis of an endocrine signal that conveys information to the brain about
the size of fat stores [10]. Thus, leptin was the first adipokine claimed to be the
“missing link” between fat and reproduction [2]. Leptin modulates satiety and
energy homeostasis [11, 12] but is also produced by the placenta. Thus, it was
suggested that the effects of placental leptin on the mother may contribute to
endocrine-mediated alterations in energy balance, such as the mobilization of
maternal fat, which occurs during the second half of pregnancy [13, 14]. In addi-
tion, leptin has been found to influence several reproductive functions, including
embryo development and implantation [15]. Moreover, animal models have dem-
onstrated that leptin-deficient mice are subfertile and fertility can be restored by
exogenous leptin [16]. This adipokine may therefore play a critical role in regulating
both energy homeostasis and the reproductive system [17].
Leptin increments the secretion of gonadotropin hormones, by acting centrally
at the hypothalamus [18]. In addition, because leptin has been shown to be
influenced by steroid hormones and can stimulate LH release, leptin may act as a
permissive factor in the development of puberty [19].
Leptin can also regulate ovary functions [20–23]. Thus, leptin resistance and
hyperleptinemia in obesity lead to altered follicle function, whereas in conditions in
which nutritional status is suboptimal, leptin deficiency results in hypothalamic-
pituitary gonadal axis dysfunction [24, 25].
In addition, a significant role of leptin in embryo implantation was proposed.
Leptin receptor (LEPR) is specifically expressed at the blastocyst stage [26], and it
was also reported that leptin is present in conditioned media from human blasto-
cysts, promoting embryo development, suggesting a function in the blastocyst-
endometrial dialog [27].
3. Leptin and placenta
The implantation involves complex and synchronized molecular and cellular
events between the implanting embryo and uterus, and these events are regulated
by autocrine and paracrine factors [5]. Fetal growth depends on the ability of the
placenta to supply nutrients adequate to meet fetal demand, which increases as
gestation progresses. Villous cytotrophoblast is a progenitor cell population that
produces daughter cells to support the expansion of the syncytium as placental
surface area increases as well as the expansion of cytotrophoblast columns, which
contain the cells destined to invade maternal decidua [28]. The placenta grows
exponentially in the first and early second trimester, but growth has slowed down
by term [29]. Therefore, placental growth, especially in early gestation, is a
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prerequisite of a high-capacity transport interface. In 1997, leptin was described as a
new placental hormone in humans [14]. In fact, during pregnancy, circulating
leptin levels are also increased due to leptin production by trophoblastic cells [30].
After delivery, leptin levels return to normal levels [31].
To alter intracellular signaling and function, leptin must bind to the receptor
(LEPR) [32]. There are six different isoforms of LEPR (a–f) that are produced by
alternative RNA splicing [33]. The only isoform that has a transmembrane domain
that is capable of activating signal transduction pathways is LEPRb, whereas the
other five short LEPR isoforms have either a truncated or no transmembrane
domain and are unable to activate signaling pathways [33]. Activation of LEPRb
results in an upregulation of a number of signal transduction pathways, including
the Janus kinase/signal transducers and activators of the transcription pathway
(JAK/STAT), as well as the mitogen-activated protein kinase (MAPK) and
phosphatidylinositol 3-kinase (PI3K) pathways [34]. Research findings do indicate
that there may be fetal-to-maternal leptin exchange across the placenta [35]. How-
ever, to date, it is not known which receptor is mediating this transportation.
Leptin has physiological effects on the placenta, including angiogenesis, growth,
and immunomodulation [13]. Leptin is now considered an important regulator
during the first stages of pregnancy, modulating proliferation, invasion, apoptosis,
and protein synthesis, in placenta [36–41].
The control of cell proliferation is critical for a correct placental development,
and it is finely regulated [42]. Altered rates of cytotrophoblast proliferation are
associated with different pathologies; levels are enhanced with increased fetal
growth (macrosomia) and diminished in fetal growth restriction [42]. Others fac-
tors in maternal circulation might coordinately stimulate proliferation, differentia-
tion, and survival [43, 44] through the activation of multiple kinases [43–45] and
phosphatases [45].
During placentation, cytotrophoblasts and syncytiotrophoblast keep a subset of
cells in direct contact to the villous basement membranes. In the extravillous com-
partment, cell proliferation favors the invasion of the uterine stroma. Similarly, in
the villous compartment, cells undergo syncytial fusion directed by specific tran-
scription factors [46].
The role of MAPK in regulating trophoblast turnover is well documented in both
human and animal systems [43, 44, 47]. Moreover, it was shown that leptin induces
proliferative activity in many human cell types [48–50], mainly via MAPK activation
[51]. We have demonstrated that leptin promotes proliferation of trophoblast cells by
this MAPK pathway [41, 52]. We have also found that leptin dose-dependently
stimulates protein synthesis by the activation of translation machinery [36, 53].
In this context, it is interesting to mention the role of Sam68, an RNA-binding
protein originally identified as the substrate of Src during mitosis and a member of
the signal transduction and activation of RNA metabolism (STAR) family [54, 55].
Leptin stimulates Tyr-phosphorylation of Sam68 in the trophoblast, mediating the
dissociation from RNA, suggesting that leptin signaling could modulate RNA
metabolism [48, 56]. Recent data indicate that microRNAs have a fundamental role
in a variety of physiological and pathological processes. In this context, studies of
microRNA expression have revealed that some microRNAs are abundantly
expressed in the placenta [57]. However, the signature of miRNAs in the placenta
has yet to be elucidated.
In placental villi, cell turnover is tightly regulated, via apoptotic cascade [49]. In
normal pregnancy, apoptosis is an essential feature of placental development, and it is
well stablished that trophoblast apoptosis increases with placental growth and
advancing gestation [50]. Leptin prevents early and late events of apoptosis via
MAPK pathway [41, 52]. The role of leptin was also studied under different stress
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conditions like serum deprivation, hyperthermia, and acidic stress [39, 40]. Under
serum deprivation, leptin increased the anti-apoptotic BCL-2 protein expression,
while it downregulated the pro-apoptotic BAX and BID proteins expression as well as
caspase-3 active form and cleaved PARP-1 fragment in Swan-71 cells and placental
explants. In addition, it was demonstrated that p53 and its phosphorylation in Ser-46
are downregulated by leptin suggesting that leptin plays a pivotal role for apoptotic
signaling by p53 [37]. Recent studies have demonstrated that MAPK and PI3K path-
ways are necessary for this anti-apoptotic leptin action, and it was also demonstrated
that MDM-2 expression is regulated by leptin [38]. In placental explants cultured at
high temperatures (40 and 42°C) and a pH acid (<7.3), the expression of Ser-46 p53,
p53AIP1, p21, and caspase-3 is increased, and, these effects are significantly attenu-
ated by leptin, indicating that leptin is a pro-survival placental cytokine [39, 40].
4. Leptin and immune system in placenta
One of the most important placental functions is to prevent embryo rejection by
the maternal immune system to enable its correct development [51]. To ensure
normal pregnancy, trophoblast differentiation requires potent immunomodulatory
mechanisms to prevent rejection of syncytiotrophoblast and invasive trophoblast by
alloreactive lymphocytes and natural killer (NK) cells present in maternal blood and
decidua [58]. Inflammatory mediators such as IL-6, IL-1β, TNFα, and prostaglan-
dins are produced and secreted by the human placenta, and these cytokines play an
important role in a number of normal and abnormal inflammatory processes,
including the initiation and progression of human labor [59–61]. There are several
homologies between the expression and regulation of cytokines and inflammation-
related genes in the placenta and in the white adipose tissue. In this regard, leptin
effects include the promotion of inflammation and the modulation of adaptive and
innate immunity [56, 62, 63]. Thus, placental leptin acts as an immune modulator,
regulating the generation of matrix metalloproteinases, arachidonic acid products,
nitric oxide production, and T cell cytokines [61]. Interestingly, leptin expression is
also regulated by IL-6, IL-1α, IL-1β, and IFN-ϒ [31, 64, 65].
It was reported that leptin stimulates IL-6 secretion in human trophoblast cells
[66, 67]. In addition, TNFα release from human placenta is also stimulated by
leptin, and it was demonstrated that NF-ҡB and PPAR-γ are important mediators of
this effect [68]. Recently, we have found that leptin induces HLA-G expression in
placenta. HLA-G has potent immunosuppressive effects promoting apoptosis of
activated CD8+ T lymphocytes, the generation of tolerogenic antigen-presenting
cells, and the prevention of NK cell-mediated cytotoxicity. These data place leptin
as a placental cytokine which confers to trophoblast cells a tolerogenic phenotype to
prevent immunological damage during the first steps of pregnancy [69].
Pro-inflammatory leptin actions may also have significant implications in the
pathogenesis of various disorders during pregnancy, such as GDM, which is char-
acterized by increased leptin expression. In this sense, placental leptin may con-
tribute to the incremented circulating levels of pro-inflammatory mediators that are
evident in these pregnancy diseases, whereas successful pregnancy is associated
with downregulation of intrauterine pro-inflammatory cytokines [9, 70, 71].
5. Leptin and gestational diabetes mellitus
Gestational diabetes mellitus, characterized by glucose intolerance diagnosed
during pregnancy, is one of the most common complications in pregnancy and
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affects 3–8% of all pregnancies [72, 73]. The prevalence of GDM has increased in
recent decades due to increased average age of pregnant females and increased risk
of obesity [74]. However, GDM is associated with numerous complications includ-
ing macrosomia, neonatal metabolic disorders, respiratory distress syndrome, and
neonatal death as well as a predisposition for the development of metabolic syn-
dromes and typ. 2 diabetes [75, 76].
The placenta is thought to have a critical role in the pathogenesis of gestational
diabetes mellitus, as GDM-associated complications resolve following delivery.
Therefore, aberrant development and functions of the placenta, including placental
overgrowth, have been implicated as important factors that contribute to GDM-
associated complications [77, 78]. GDM is associated with insulin resistance,
hyperinsulinemia, and hyperleptinemia, and these GDM-associated conditions dis-
turb placental nutrient transport and fetal nutrient supply [79, 80].
It has been found that leptin and LEPR expressions are increased in placenta
from GDM [9, 70], and, in fact leptin was proposed as a first-trimester biochemical
predictor of GDM [81, 82]. In addition it was suggested that hyperinsulinemia may
regulate placental leptin production acting as a circulating signal to control fetal
homeostasis [73, 83]. Furthermore, it is thought that maternal glucose regulates
cord blood leptin levels, and this could explain why newborns exposed to GDM
have an increased risk of obesity [84]. Comparison of the placental gene expression
profile between normal and diabetic pregnancies indicates that increased leptin
synthesis in GDM is correlated with higher production of pro-inflammatory cyto-
kines such as IL-6 and TNFα, causing a chronic inflammatory environment that
enhances leptin production [85].
Our group has reported that insulin induces leptin expression in trophoblastic
cells by increasing leptin promoter activity [86]. It is known that leptin and insulin
share several signaling pathways, such as JAK2/STAT-3, MAPK, and PI3K. More-
over, we could demonstrate that in GDM, the basal phosphorylation of STAT-3,
MAPK 1/3, and Akt is increased in the placenta, with resistance to a further stimu-
lation with leptin or insulin in vitro, suggesting synergistic interaction between
insulin and leptin signaling and action in human placenta [9].
On the other hand, GDM is associated with increased incidence of
polyhydramnios, due to an increase in amniotic fluid volume, suggesting that
aquaporins (AQP), such as AQP9 expression, could be altered in GDM [87, 88].
Besides, when maternal circulating glucose levels are controlled, they have normal
amniotic fluid volume. AQP9 is also a transporter for glycerol and may also provide
this substrate to the fetus. In this context, we have found that AQP9 mRNA and
protein expressions are overexpressed in placentas from women with GDM. These
data could suggest that during GDM the overexpression of AQP9, which correlates
with higher leptin plasma levels, increments glycerol transport to the fetus which
may help to cover the increase in energy needs that may occur during this gesta-
tional metabolic disorder [89].
Nevertheless, even though any nutritional or lifestyle intervention aimed to
reduce weight produce a decrease in leptin levels, both in gestational diabetes and in
general population, no therapeutic intervention, using leptin as a pharmacological
target, has so far been used in the management of gestational diabetes.
6. Leptin and microRNAs
Gene expression can be regulated by short (18–22-nucleotide) noncoding RNAs,
microRNAs, derived from long primary transcripts (pre-microRNAs) through
sequential processing by two enzymes, Drosha and Dicer, and then incorporated
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into the RNA silencing complex, where they target homologous mRNAs. In mice,
loss or inactivation of Dicer leads to multiple developmental defects [90, 91], and it
has been demonstrated that in human placenta, cytotrophoblast proliferation is
increased following Dicer [92]; however, the individual microRNAs responsible for
these effects are unknown. In silico network analysis identified microRNAs (miR-
145 and let-7a) that influence the expression of components of nodal signaling
pathways. The large network is bridged by nodal molecules, such as mitogen-
activated protein kinase (MAPK1/2), and AKT, which are recognized components
of pro-mitogenic signaling pathways [20]. In fact, the role of MAPK1/2 in regulating
trophoblast turnover is well documented in both human and animal systems
[43, 44, 47]. In this context, we have reported an increased activation of MAPK 1/2
in response to leptin in trophoblastic cells from the human placenta. Thus, it is
tempting to speculate that altered microRNAs expression influences the leptin
expression and contributes to the pathogenesis of the GDM. However, the signature
of microRNAs in the leptin expression in the placenta both in normal pregnancy
and GDM remains to be elucidated. Therefore, it will be interesting to determine, in
future studies, the combined role of these microRNAs in the leptin expression in
normal placenta and in placenta from pregnancy pathology associated with altered
placental growth (e.g., GDM) in order to clarify the regulation of placental growth
by leptin.
7. Leptin in fetal development
Obesity is associated with significantly elevated plasma leptin concentrations
due to an increase in white adipose tissue compared with healthy individuals [93].
As obesity rates are increasing rapidly in the Western world, so is increasing the
number of obese women who become pregnant. Importantly, obese pregnant
women have significantly elevated plasma leptin concentrations compared with
nonobese pregnant women throughout pregnancy [94]. Even though no differences
in placental leptin production has been shown, there is a downregulation of LEPRb
expression in the placenta of obese mothers, which would cause placental leptin
resistance (in addition to the central leptin resistance that occurs during normal
pregnancy) that may be attempting to modulate fetal growth under high-energy
conditions [95, 96]. Despite the complications associated with pregnancies in obese
women, the offspring may be growth restricted, normal weight, or macrosomic.
However, after birth, babies born from obese mothers are exposed to elevated
leptin concentrations in the maternal milk [97], which suggests that the postnatal
environment may increase infant growth and development, increasing the risk of
developing a number of diseases in adulthood. Therefore, alterations in maternal-
placental-fetal leptin exchange may modify the development of the fetus and
contribute to the increased risk of developing disease in adulthood.
8. Conclusions
In conclusion, it could be affirmed that leptin controls reproduction depending
on the energy state of the body and sufficient leptin levels are a prerequisite for the
maintenance of reproductive capacity. The present review was focused in placental
leptin effects during gestation, when leptin levels are increased due to leptin pro-
duction by trophoblastic cells. Thus, leptin has a wide range of biological functions
on trophoblast cells and a role in successful establishment of pregnancy. In this
sense, leptin promotes proliferation, protein synthesis, and survival of placental
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cells. These actions are very important since cell proliferation and apoptotic cas-
cades are critical for the correct placental development and function. Moreover, an
important role of leptin in the regulation of immune mechanisms at the maternal
interface has been suggested.
Observational studies have demonstrated that states of leptin overabundance or
resistance can be associated with GDM. Moreover, it is also established that obesity
may lead to deregulation in leptin function that results in maternal disease and
clinical studies demonstrate an impact of obesity with an increased risk of a number
of diseases in adulthood, including metabolic disease. In this context, leptin dereg-
ulation has been implicated in the pathogenesis of GDM. It is well accepted that
leptin and LEPR expressions are increased in placentas from GDM, which may be
relevant to control fetal homeostasis. Moreover, a role for microRNAs in the regu-
lation of placental growth has been suggested, and expression profiling in the
studies has shown expression and gestational changes in microRNA levels that
demand functional evaluation. Further investigation is needed to fully elucidate the
association of leptin with GDM and to stablish leptin as a biomarker for this
pathology or the development of microRNA-based approaches to therapeutic
targeting for correcting the abnormal placental growth and cell turnover seen in
GDM.
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